Thermal ablation (TA) is now a widely used treatment for cervical precancer in low- and middle-income countries.
Over the past decade, TA devices have been redesigned to be more portable, user-friendly, and affordable.
This analysis combines data from three large randomized clinical trials comparing the efficacy, safety, and acceptability of TA with those of the previous standard, gas-based cryotherapy.
